TY  - GEN
AU  - Bruzzone,M
AU  - Centurioni,M G
AU  - Giglione,P
AU  - Gualco,M
AU  - Merlo,D F
AU  - Miglietta,L
AU  - Cosso,M
AU  - Giannelli,F
AU  - Cristoforoni,P
AU  - Ferrarini,M
TI  - Second-line treatment with intravenous gemcitabine and oral etoposide in platinum-resistant advanced ovarian cancer patients: results of a phase II study
SN  - 1423-0232
PY  - 2011///0928
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - CA-125 Antigen
KW  - blood
KW  - Deoxycytidine
KW  - administration & dosage
KW  - Drug Resistance, Neoplasm
KW  - Etoposide
KW  - Female
KW  - Humans
KW  - Middle Aged
KW  - Ovarian Neoplasms
KW  - Platinum
KW  - therapeutic use
KW  - Survival Analysis
KW  - Treatment Outcome
KW  - Gemcitabine
N1  - Publication Type: Clinical Trial, Phase II; Journal Article
UR  - https://doi.org/10.1159/000328451
ER  -